Related Experiment Video
Updated: Sep 13, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
The usability and feasibility of a self-compassion chatbot (COMPASS) for youth living with type 1 diabetes
Anna L Boggiss1,2, Katie Babbott1,3, Ānna Milford1
1Department of Psychological Medicine, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, Aotearoa New Zealand.
Aim:
Although it is well established that youth with type 1 Diabetes (T1D) experience high rates of distress, current clinical care is often under-resourced and unable to provide sufficient or timely psychological support. The current study was designed to evaluate the safety, usability and feasibility of 'COMPASS,' a self-compassion chatbot intervention.
Methods:
Forty adolescents (aged 12-16 years) living with T1D participated in a 12-week, single-group feasibility study using a mixed methods approach. Usability was assessed via qualitative feedback and interviews, feasibility through app analytics and recruitment data, and safety by utilisation of distress risk management protocols. Psychosocial measures (including diabetes distress, strengths and resilience, self-efficacy, self-compassion, self-care behaviours and emotional well-being) were collected at baseline, 6- and 12-week follow-ups, alongside HbA1c at baseline and 12 weeks.
Results:
Of 40 participants recruited, 32 (80%) completed the study. On average, participants completed 95% of modules started. Follow-up assessments showed promising reductions in diabetes distress, and improvements in resilience, self-efficacy, self-compassion and emotional well-being. Qualitative analysis highlighted strengths in engagement and relevance of information covered. Areas for improvement included increasing decision-making support to help alleviate the felt burden of diabetes.
Conclusions:
The COMPASS chatbot was demonstrated to be safe, feasible and acceptable to adolescents living with T1D. Future research aims to conduct a hybrid type 1 effectiveness-implementation trial that will leverage updates in artificial intelligence to increase the flexibility and tailoring of responding.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Self-Presentation: Self-Monitoring and Self-Handicapping
Empathy

